v.rasmussen
Submits third-party assay reports on material purchased directly. Based in Antalya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.54%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043336 | Liraglutide | CPC | CPC-2602-G1978 | Janoshik | 2026-Q3 | 97.69 | 4.58 | 104.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041935 | Semaglutide | TFC | TFC-2604-X4301 | VendorInvestigate | 2026-Q3 | 98.54 | 4.54 | 98.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043419 | Sermorelin | WXT | WXT-2608-P4867 | Janoshik | 2026-Q3 | 98.40 | 3.38 | 106.3 | Supplier-supplied | 0 | PASS |
| AX-2026-043499 | MOTS-c | BCH | BCH-2511-L5815 | Medutest | 2026-Q2 | 97.04 | 3.58 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018689 | SS-31 (Elamipretide) | QYB | QYB-2506-S6277 | VendorInvestigate | 2025-Q3 | 99.88 | 3.59 | 89.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005220 | IGF-1 DES (1-3) | SSA | SSA-2403-F6661 | Medutest | 2024-Q2 | 99.93 | 3.91 | 106.0 | Supplier-supplied | 0 | PASS |
| AX-2024-004682 | Tirzepatide | TFC | TFC-2401-J7929 | Janoshik | 2024-Q1 | 98.91 | 6.67 | — | Supplier-supplied | 2 | MARGINAL |